Paper2467380
Control of angiogenesis with synthetic heparin substitutes.
Folkman J and 4 others. Science, 1989. Cited by 255 papers, by iCite.
Cite this record
ConductScience Library. Control of angiogenesis with synthetic heparin substitutes. Papers, record 2467380. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2467380
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclodextrins | Major topic |
| Dextrins | Major topic |
| Heparin | Major topic |
| Neovascularization, Pathologic | Major topic |
| Starch | Major topic |
| Steroids | Major topic |
| Animals | |
| Heparan Sulfate | |
| Rabbits | |
| Structure-Activity Relationship |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01-CA37395 | NCI NIH HHS | United States | R01CA037395 | PubMed and NIH |
Source NIH RePORTER
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 255 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27713265 | The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis. | Pharmaceuticals (Basel) | 2010 | https://conductscience.org/library/papers/27713265 | PubMed |
| 25944736 | (2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis. | PLoS One | 2015 | https://conductscience.org/library/papers/25944736 | PubMed |
| 25762641 | P-selectin-mediated platelet adhesion promotes tumor growth. | Oncotarget | 2015 | https://conductscience.org/library/papers/25762641 | PubMed |
| 23398560 | Sulfation patterns determine cellular internalization of heparin-like polysaccharides. | Mol Pharm | 2013 | https://conductscience.org/library/papers/23398560 | PubMed |
| 20814668 | Analysis and characterization of heparin impurities. | Anal Bioanal Chem | 2011 | https://conductscience.org/library/papers/20814668 | PubMed |
| 20125158 | The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. | Br J Cancer | 2010 | https://conductscience.org/library/papers/20125158 | PubMed |
| 19738120 | Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19738120 | PubMed |
| 19554729 | Nanoscale growth factor patterns by immobilization on a heparin-mimicking polymer. | J Am Chem Soc | 2008 | https://conductscience.org/library/papers/19554729 | PubMed |
| 19240943 | Lessons learned from the contamination of heparin. | Nat Prod Rep | 2009 | https://conductscience.org/library/papers/19240943 | PubMed |
| 18940748 | Idiopathic and recurrent thromboembolic phenomena in cancer patients. | Clin Transl Oncol | 2008 | https://conductscience.org/library/papers/18940748 | PubMed |
| 18264127 | Enhanced antithrombotic effects of unfractionated heparin in rats after repeated oral doses and its relationship to endothelial heparin concentration. | Br J Pharmacol | 2008 | https://conductscience.org/library/papers/18264127 | PubMed |
| 18097470 | Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumors. | Gene Ther | 2008 | https://conductscience.org/library/papers/18097470 | PubMed |
| 17916399 | Heparin-mimetic sulfated peptides with modulated affinities for heparin-binding peptides and growth factors. | Peptides | 2007 | https://conductscience.org/library/papers/17916399 | PubMed |
| 16954815 | Synthetic oligosaccharide stimulates and stabilizes angiogenesis: structure-function relationships and potential mechanisms. | J Cardiovasc Pharmacol | 2006 | https://conductscience.org/library/papers/16954815 | PubMed |
| 16310167 | Enzymatic synthesis of heparin related polysaccharides on sensor chips: rapid screening of heparin-protein interactions. | Biochem Biophys Res Commun | 2006 | https://conductscience.org/library/papers/16310167 | PubMed |
| 16096774 | [Antiangiogenic and anti-immunosuppressive therapeutic strategies in human head and neck squamous cell carcinoma (HNSCC)]. | Mund Kiefer Gesichtschir | 2005 | https://conductscience.org/library/papers/16096774 | PubMed |
| 16044325 | Inhibitory effect of triamcinolone acetonide on corneal neovascularization. | Graefes Arch Clin Exp Ophthalmol | 2006 | https://conductscience.org/library/papers/16044325 | PubMed |
| 12927058 | Adhesion inhibition "in vitro" by heparin derivatives correlates with their activity on angiogenesis in mice. | J Cell Mol Med | 2003 | https://conductscience.org/library/papers/12927058 | PubMed |
| 12242295 | Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate. | Mol Cell Biol | 2002 | https://conductscience.org/library/papers/12242295 | PubMed |
| 11994763 | Effect of sulfated beta-cyclodextrin, a water soluble cycloamylose, on the promotion and/or inhibition of angiogenesis. | Pathol Oncol Res | 2002 | https://conductscience.org/library/papers/11994763 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2467380
GET https://conductscience.org/api/papers/v1/2467380/cited_by?page=2